Stocks
Amicus Therapeutics, Inc.FOLD
NASDAQHealthcareBiotechnology$14.37+0.00%
Focused on therapies for rare metabolic diseases, the company develops and commercializes treatments targeting lysosomal storage disorders such as Fabry and Pompe disease. Its lead products include Galafold, an oral therapy for Fabry disease, and the Pompe disease combination therapy Pombiliti and O...
Market Cap: $4.5B52W Range: $5.51 – $14.39
This page tracks all publicly disclosed congressional trades in Amicus Therapeutics, Inc. (FOLD), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 0 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-04-10 | Daniel Goldman | sell | $1K – $15K |